Multiple Strains News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple strains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Strains Today - Breaking & Trending Today

Avast Releases FREE Ransomware Decryptor for Multiple Strains—How to Get One

Avast released free ransomware decryptor that victims could use on multiple strains. Here’s how to get one. ....

Krasnodarskiy Kray , Ransomware Decryptors , Sean Gallup Getty , Blackmatter Ransomware , Teejay Boris , Ransomware Decryptor , Tech Times , Multiple Strains , Get One , Getty Images , Latest Ransomware Family , Cybercriminal Payback , Payments After Code Mistake Found , Avast Release Ransomware Decryptor , Vast Ransomware ,

Biohaven Reports First Quarter 2021 Financial Results and Recent Business Developments

NEW HAVEN, Conn., May 10, 2021 /PRNewswire/ Â Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the Company ), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases including rare disorders, today reported financial results for the first quarter ended March 31, 2021, and provided a review of recent accomplishments and anticipated upcoming milestones.
Vlad Coric, M.D., Chief Executive Officer of Biohaven commented, NURTEC ODT s performance, with its differentiated efficacy and safety profile, continues to be bolstered by overwhelmingly positive patient and provider sentiment to date. We are highly encouraged by the continued success of NURTEC ODT, with net revenues of $43.8 million in the first quarter exceeding expectations. ....

South Africa , New Haven , United States , United Arab Emirates , Yale University , South African , Medison Pharma , David Spiegel , Mike Beyer , Biohaven Neuroinnovation , Genpharm Services , Exchange Commission On , World Health Organization , Drug Administration , Melinda Gates Foundation , Sam Brown Inc , Biohaven Pharmaceutical Holding Company Ltd , Development Rd Expenses , United Arab Emirates Ministry Of Health , European Medicines Agency , Israeli Ministry Of Health , Kleo Pharmaceuticals Inc , Biohaven Pharmaceutical Holding Company , Chief Executive Officer , Recent Business , Acute Treatment ,

Biohaven Reports First Quarter 2021 Financial Results and Recent Business Developments

Biohaven Reports First Quarter 2021 Financial Results and Recent Business Developments
- Exceeded expectations of NURTEC™ ODT (rimegepant) with net product revenue of $43.8 million for the first quarter of 2021, totaling $107.4 million in net product revenue since launch in March 2020
- Continued brand momentum for NURTEC ODT totaling more than 600,000 prescriptions from product launch to date, with more than 33,000 unique prescribers
- Advanced Neuroinnovation™ Platform with multiple Phase 3 studies results expected within the next year, and enrolled first patient in Phase 2/3 trial of oral zavegepant, prompting $100 million Royalty Pharma milestone payment
News provided by
Share this article
Share this article
As a result of an inadvertent error, the version of the earnings release Biohaven Pharmaceutical Holding Company Ltd. ( Biohaven ) issued before market open on May 10, 2021 (the Original Earnings Release ) included certain inaccurate financ ....

South Africa , New Haven , United States , United Arab Emirates , Yale University , South African , Medison Pharma , David Spiegel , Mike Beyer , Biohaven Neuroinnovation , Genpharm Services , Exchange Commission On , World Health Organization , Drug Administration , Melinda Gates Foundation , Sam Brown Inc , Biohaven Pharmaceutical Holding Company Ltd , Development Rd Expenses , United Arab Emirates Ministry Of Health , European Medicines Agency , Israeli Ministry Of Health , Kleo Pharmaceuticals Inc , Biohaven Pharmaceutical Holding Company , Chief Executive Officer , Recent Business , Acute Treatment ,

Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments

Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments
- NURTEC® ODT (rimegepant) net product revenues for the fourth quarter of 2020 were $35.1 million, representing a 98% increase compared to the third quarter of 2020, and $63.6 million for calendar year 2020 following U.S. commercial launch in March of 2020
- Exceeded market expectations with robust growth of NURTEC ODT totaling over 337,000 prescriptions in 2020 and over 24,000 unique prescribers
- Regulatory filing for rimegepant in Europe submitted and accepted for review by European Medicines Agency for dual-acting (acute and prevention) indication for treatment of migraine
- Life-cycle management studies for CGRP-antagonist program underway, including initiation of Phase 4 study of NURTEC ODT in pediatric migraine ....

United States , Science Park , South Africa , New Haven , United Arab Emirates , Yale University , South African , David Spiegel , Sosei Heptares , Artizan Biosciences , Bristol Myers Squibb , Maryellen Mcquade , Medison Pharma , Richard Flavell , Mike Beyer , Korean Ministry Of Food , Exchange Commission On , Genpharm Services , Healey Center , International Partnerships To Accelerate The Accessibility , Melinda Gates Foundation , Advisory Committee , Sam Brown Inc , Biohaven Pharmaceutical Holding Company Ltd , Company Annual Report On Form , Biohaven Pharmaceutical Holding ,

Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments

Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Science Park , South Africa , New Haven , United Arab Emirates , Yale University , South African , David Spiegel , Sosei Heptares , Artizan Biosciences , Bristol Myers Squibb , Maryellen Mcquade , Medison Pharma , Richard Flavell , Mike Beyer , Korean Ministry Of Food , Exchange Commission On , Genpharm Services , Healey Center , International Partnerships To Accelerate The Accessibility , Melinda Gates Foundation , Advisory Committee , Sam Brown Inc , Biohaven Pharmaceutical Holding Company Ltd , Company Annual Report On Form , Biohaven Pharmaceutical Holding ,